These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19474823)

  • 21. Regression of parathyroid gland swelling by treatment with cinacalcet.
    Terawaki H; Nakano H; Takeguchi F; Hasegawa T; Nakayama M; Okazaki M; Hosoya T
    Nephrol Dial Transplant; 2009 Feb; 24(2):690-1; author reply 691-2. PubMed ID: 18987257
    [No Abstract]   [Full Text] [Related]  

  • 22. Cinacalcet: a new treatment for secondary hyperparathyroidism in patients receiving hemodialysis.
    Byrnes CA; Shepler BM
    Pharmacotherapy; 2005 May; 25(5):709-16. PubMed ID: 15899733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cinacalcet for managing secondary hyperparathyroidism in dialysis patients in clinical practice in Belgium: a 16-month observational study (ECHO-B).
    Debelle F; Meeus G; Dratwa M; Maes B; Vanholder R; Albert A; Schutyser E; Jadoul M
    Acta Clin Belg; 2013; 68(4):275-81. PubMed ID: 24455797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
    Wheeler DC; London GM; Parfrey PS; Block GA; Correa-Rotter R; Dehmel B; Drüeke TB; Floege J; Kubo Y; Mahaffey KW; Goodman WG; Moe SM; Trotman ML; Abdalla S; Chertow GM; Herzog CA;
    J Am Heart Assoc; 2014 Nov; 3(6):e001363. PubMed ID: 25404192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
    Iseki K
    Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
    Drüeke TB
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S2-12. PubMed ID: 19032522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
    Moe SM; Abdalla S; Chertow GM; Parfrey PS; Block GA; Correa-Rotter R; Floege J; Herzog CA; London GM; Mahaffey KW; Wheeler DC; Dehmel B; Goodman WG; Drüeke TB;
    J Am Soc Nephrol; 2015 Jun; 26(6):1466-75. PubMed ID: 25505257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism.
    Yousaf F; Charytan C
    Ren Fail; 2014 Feb; 36(1):131-8. PubMed ID: 24060145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism (SHPT) in hemodialysis patients.
    Aladrén Regidor MJ
    Clin Nephrol; 2009 Feb; 71(2):207-13. PubMed ID: 19203518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cinacalcet on gastrointestinal hormone release in patients with secondary hyperparathyroidism undergoing dialysis.
    Díez JJ; Miguel JL; Codoceo R; Iglesias P; Bajo MA; Sánchez C; Del Peso G; Gil F; Martinez-Ara J; Gancedo PG; Selgas R
    Nephrol Dial Transplant; 2008 Apr; 23(4):1387-95. PubMed ID: 18045826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.
    Lindberg JS; Culleton B; Wong G; Borah MF; Clark RV; Shapiro WB; Roger SD; Husserl FE; Klassen PS; Guo MD; Albizem MB; Coburn JW
    J Am Soc Nephrol; 2005 Mar; 16(3):800-7. PubMed ID: 15689407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cinacalcet, fetuin-A and interleukin-6.
    Marino A; Giotta N
    Nephrol Dial Transplant; 2008 Apr; 23(4):1460-1; author reply 1461-2. PubMed ID: 18065786
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of cinacalcet in treating secondary hyperparathyroidism.
    Brommage D; Gallgano C
    Nephrol Nurs J; 2005; 32(2):229-31. PubMed ID: 15889812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients.
    Owda AK; Alam MG; Kumar J
    N Engl J Med; 2004 Jul; 351(2):188-9; author reply 188-9. PubMed ID: 15247361
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients.
    Hirai T; Nakashima A; Takasugi N; Yorioka N
    Ther Apher Dial; 2010 Dec; 14(6):577-82. PubMed ID: 21118366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Shigematsu T; Akizawa T; Uchida E; Tsukamoto Y; Iwasaki M; Koshikawa S;
    Am J Nephrol; 2009; 29(3):230-6. PubMed ID: 18797166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Six cases of successful cinacalcet cessation in haemodialysis patients treated for secondary hyperparathyroidism.
    Jean G; Chazot C; Charra B
    Nephrol Dial Transplant; 2007 Jul; 22(7):2102-3. PubMed ID: 17395648
    [No Abstract]   [Full Text] [Related]  

  • 38. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
    Parfrey PS; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Dehmel B; Trotman ML; Modafferi DM; Goodman WG
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4834-44. PubMed ID: 24108314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.
    Malluche HH; Monier-Faugere MC; Wang G; Frazã O JM; Charytan C; Coburn JW; Coyne DW; Kaplan MR; Baker N; McCary LC; Turner SA; Goodman WG
    Clin Nephrol; 2008 Apr; 69(4):269-78. PubMed ID: 18397701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fooling the parathyroid gland--will there be health benefits?
    Curhan G
    N Engl J Med; 2004 Apr; 350(15):1565-7. PubMed ID: 15071132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.